-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 HyNo5YNvxHxWpmk46HDaGvQKKZ8oOl05L3HASkkdk4n1BX3lnukkc6WXrOhFr/mG
 oWfi9U3yYbiZ4649Brgvgw==

<SEC-DOCUMENT>9999999997-07-036149.txt : 20070807
<SEC-HEADER>9999999997-07-036149.hdr.sgml : 20070807
<ACCEPTANCE-DATETIME>20070807103846
<PAPER>
ACCESSION NUMBER:		9999999997-07-036149
CONFORMED SUBMISSION TYPE:	CERTNAS
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20070806
DATE AS OF CHANGE:		20070807
EFFECTIVENESS DATE:		20070806

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CUMBERLAND PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0001087294
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000

	FILING VALUES:
		FORM TYPE:		CERTNAS
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33637
		FILM NUMBER:		07072772

	BUSINESS ADDRESS:	
		STREET 1:		2525 WEST END AVENUE
		STREET 2:		SUITE 950
		CITY:			NASHVILLE,
		STATE:			TN
		ZIP:			37203
		BUSINESS PHONE:		615-255-0068

	MAIL ADDRESS:	
		STREET 1:		2525 WEST END AVENUE
		STREET 2:		SUITE 950
		CITY:			NASHVILLE
		STATE:			TN
		ZIP:			37203
</SEC-HEADER>
<DOCUMENT>
<TYPE>CERTNAS
<SEQUENCE>1
<FILENAME>9999999997-07-036149.paper
<DESCRIPTION>AUTO-GENERATED PAPER DOCUMENT
<TEXT>
This document was generated as part of a paper submission.
Please reference the Document Control Number 07072772 for access to the original document.
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
